Switch to:
To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:
Insider Position Date Buy/Sell Shares Shares Owned Following This Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Goldberg Leonard RDirector2014-08-04Sell7,92922,870$32.65258.94.99Link
Goldberg Leonard RDirector2014-07-02Sell7,982166,793$32.8261.84.51Link
Goldberg Leonard RDirector2014-06-18Sell8,033166,793$33.41268.42.6Link
Hedges BartonCEO
(Click for the stocks that their CEOs have bought)
2014-06-16Sell2,500196,182$33.3683.42.76Link
Goldberg Leonard RDirector2014-06-03Sell7,857166,793$32.25253.46.29Link
Hedges BartonCEO2014-05-20Sell15,812198,682$31.51498.28.79Link
Goldberg Leonard RDirector2014-05-14Sell7,888166,793$32.06252.96.92Link
Hedges BartonCEO2014-05-13Sell16,071198,682$32.64524.65.02Link
Diaz SherryController2014-05-09Sell1,42924,586$32.1245.96.72Link
Goldberg Leonard RDirector2014-05-02Sell7,863163,555$32.432555.7Link
Goldberg Leonard RDirector2014-04-16Sell7,754163,555$31.44243.89.03Link
Goldberg Leonard RDirector2014-04-02Sell7,935163,555$32.82260.44.45Link
Goldberg Leonard RDirector2014-03-19Sell7,973163,555$32.97262.93.97Link
Hedges BartonCEO2014-03-17Sell2,500198,682$32.79824.54Link
Goldberg Leonard RDirector2014-03-04Sell7,664163,555$30.95237.210.76Link
Goldberg Leonard RDirector2014-02-19Sell7,885163,555$32.1253.16.79Link
Goldberg Leonard RDirector2014-02-04Sell7,742163,555$30.7423811.52Link
Goldberg Leonard RDirector2014-01-15Sell8,068163,555$33.41269.62.6Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK